Yea-Ji Lee, Jaemoon Lee, Seung-Wan Hong, Seong-Hyop Kim
{"title":"The Type of Preoperative Oral Antithrombotics as a Risk Factor for Venous Thromboembolism After Hip Surgery: A Retrospective Study.","authors":"Yea-Ji Lee, Jaemoon Lee, Seung-Wan Hong, Seong-Hyop Kim","doi":"10.3390/medicina61040729","DOIUrl":null,"url":null,"abstract":"<p><p><i>Background and Objectives</i>: Hip surgery is increasingly performed among elderly patients. Oral antithrombotics, which are taken for patients' underlying diseases, are a main concern regarding perioperative bleeding. Postoperative venous thromboembolism (VTE) is a leading cause of mortality after hip surgery. Therefore, administration of preoperative oral antithrombotics is a double-edged sword in hip surgery. In this study, we examined the correlation between the occurrence of postoperative VTE and the type of oral antithrombotics administered preoperatively. <i>Materials and Methods</i>: We analyzed the medical records of 601 patients aged 19 and over who underwent hip surgery from January 2021 to June 2023. The patients were assigned to two groups as follows: Groups VTE+ (patients who developed postoperative VTE) and VTE- (patients who did not develop postoperative VTE), respectively. <i>Results</i>: Of the 139 patients who had been taking oral antithrombotics for 6 months or more, 24 were allocated to group VTE+ and 115 to group VTE-, respectively. The number of patients who took clopidogrel and cilostazol was significantly higher in groups VTE- and VTE+, respectively (12.5 vs. 33.9%, <i>p</i> = 0.038, odds ratio (OR) = 0.278, 95% confidence interval (CI) = 0.078-0.991; 20.8 vs. 5.2%, <i>p</i> = 0.010, 95% CI = 1.325-17.245; group VTE+ vs. group VTE-). Preoperative albumin levels were significantly lower in group VTE+ (3.4 ± 0.6 g/dL vs. 3.7 ± 0.4 g/dL, <i>p</i> = 0.004, OR = 0.285, 95% CI = 0.115-0.702). In multivariate regression analysis, the results were statistically significant for clopidogrel, cilostazol, and preoperative albumin levels (<i>p</i> = 0.035, OR = 0.237, 95% CI = 0.062-0.901; <i>p</i> = 0.011, OR = 6.479, 95% CI = 1.542-27.226; <i>p</i> = 0.002, OR = 0.211, 95% CI = 0.080-0.558). <i>Conclusions</i>: Among the patients who had been taking oral antithrombotics for ≥6 months, clopidogrel had a prophylactic effect, but cilostazol showed an aggravating effect on postoperative VTE in hip surgery. Preoperative hypoalbuminemia increases the risk of postoperative VTE in hip surgery.</p>","PeriodicalId":49830,"journal":{"name":"Medicina-Lithuania","volume":"61 4","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12028487/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicina-Lithuania","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/medicina61040729","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background and Objectives: Hip surgery is increasingly performed among elderly patients. Oral antithrombotics, which are taken for patients' underlying diseases, are a main concern regarding perioperative bleeding. Postoperative venous thromboembolism (VTE) is a leading cause of mortality after hip surgery. Therefore, administration of preoperative oral antithrombotics is a double-edged sword in hip surgery. In this study, we examined the correlation between the occurrence of postoperative VTE and the type of oral antithrombotics administered preoperatively. Materials and Methods: We analyzed the medical records of 601 patients aged 19 and over who underwent hip surgery from January 2021 to June 2023. The patients were assigned to two groups as follows: Groups VTE+ (patients who developed postoperative VTE) and VTE- (patients who did not develop postoperative VTE), respectively. Results: Of the 139 patients who had been taking oral antithrombotics for 6 months or more, 24 were allocated to group VTE+ and 115 to group VTE-, respectively. The number of patients who took clopidogrel and cilostazol was significantly higher in groups VTE- and VTE+, respectively (12.5 vs. 33.9%, p = 0.038, odds ratio (OR) = 0.278, 95% confidence interval (CI) = 0.078-0.991; 20.8 vs. 5.2%, p = 0.010, 95% CI = 1.325-17.245; group VTE+ vs. group VTE-). Preoperative albumin levels were significantly lower in group VTE+ (3.4 ± 0.6 g/dL vs. 3.7 ± 0.4 g/dL, p = 0.004, OR = 0.285, 95% CI = 0.115-0.702). In multivariate regression analysis, the results were statistically significant for clopidogrel, cilostazol, and preoperative albumin levels (p = 0.035, OR = 0.237, 95% CI = 0.062-0.901; p = 0.011, OR = 6.479, 95% CI = 1.542-27.226; p = 0.002, OR = 0.211, 95% CI = 0.080-0.558). Conclusions: Among the patients who had been taking oral antithrombotics for ≥6 months, clopidogrel had a prophylactic effect, but cilostazol showed an aggravating effect on postoperative VTE in hip surgery. Preoperative hypoalbuminemia increases the risk of postoperative VTE in hip surgery.
背景和目的:老年患者越来越多地接受髋关节手术。口服抗血栓药物,这是采取病人的基础疾病,是一个主要关注围手术期出血。术后静脉血栓栓塞(VTE)是髋关节手术后死亡的主要原因。因此,术前口服抗栓药物在髋关节手术中是一把双刃剑。在这项研究中,我们检查了术后静脉血栓栓塞的发生与术前口服抗血栓药物的类型之间的关系。材料和方法:我们分析了2021年1月至2023年6月期间接受髋关节手术的601例19岁及以上患者的病历。将患者分为以下两组:VTE+组(术后发生VTE的患者)和VTE-组(术后未发生VTE的患者)。结果:139例口服抗血栓药物治疗6个月及以上的患者中,VTE+组24例,VTE-组115例。VTE-组和VTE+组服用氯吡格雷和西洛他唑的患者人数分别显著高于VTE-组(12.5 vs. 33.9%, p = 0.038,优势比(OR) = 0.278, 95%可信区间(CI) = 0.078 ~ 0.991;20.8 vs. 5.2%, p = 0.010, 95% CI = 1.325 ~ 17.245;VTE+组与VTE-组)。术前白蛋白水平明显低于VTE+组(3.4±0.6 g/dL vs 3.7±0.4 g/dL, p = 0.004, OR = 0.285, 95% CI = 0.115 ~ 0.702)。在多因素回归分析中,氯吡格雷、西洛他唑和术前白蛋白水平的差异均有统计学意义(p = 0.035, OR = 0.237, 95% CI = 0.062 ~ 0.901;p = 0.011, OR = 6.479, 95% CI = 1.542 ~ 27.226;p = 0.002, OR = 0.211, 95% CI = 0.080-0.558)。结论:在口服抗栓药物≥6个月的患者中,氯吡格雷具有预防作用,但西洛他唑对髋关节术后静脉血栓栓塞有加重作用。术前低白蛋白血症增加髋关节手术后静脉血栓栓塞的风险。
期刊介绍:
The journal’s main focus is on reviews as well as clinical and experimental investigations. The journal aims to advance knowledge related to problems in medicine in developing countries as well as developed economies, to disseminate research on global health, and to promote and foster prevention and treatment of diseases worldwide. MEDICINA publications cater to clinicians, diagnosticians and researchers, and serve as a forum to discuss the current status of health-related matters and their impact on a global and local scale.